{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:10:17Z","timestamp":1786119017114,"version":"build-2736575974"},"reference-count":116,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"crossref","award":["MRFCRI000020"],"award-info":[{"award-number":["MRFCRI000020"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2016277"],"award-info":[{"award-number":["GNT2016277"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosdigitalhealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Digit Health"],"abstract":"<jats:p>Risk prediction tools assist pharmacists to identify and prioritise hospitalised patients at risk of drug-related problems (DRPs) requiring clinical review. This umbrella review identifies existing risk prediction tools, summarises their performance, and highlights factors important for prioritising hospitalised adults at risk of DRPs for clinical review. A systematic search of three bibliographic databases from January 2010 to March 2024, identified systematic reviews that qualitatively or quantitatively examined patient- and\/or medication-related factors in risk prediction or prioritisation models or tools for adult inpatients at risk of DRPs. Extracted data included citation, review type, number and date range of primary studies, population, setting, outcomes, and key risk factors. Risk prediction tools were summarised by country, sample size, performance metrics (discrimination, sensitivity, calibration), number of risk factors, and external validation. All extracted data was checked by a second reviewer. The standardized Joanna Briggs Institute critical appraisal instruments were used to assess the quality of eligible studies. Twenty systematic reviews met our inclusion criteria, of which 18 were of sufficient quality for synthesis. Selected articles covered 171 unique primary studies and 32 risk prediction tools, of which 12 demonstrated acceptable or good discrimination of which four also had good calibration. Two tools showed the highest potential for future clinical use based on their performance metrics and external validation data but would benefit from further validation in diverse populations. Commonly reported risk factors for DRPs were psycholeptic medications (reported in 13 systematic reviews), age, comorbidities and reduced renal function (n\u2009=\u200912 reviews). Based on the reviews included, no tools appear to be yet suitable for routine clinical practice due to limited external validation, calibration and unclear risk factor definitions; however, some show promise for further development and testing. Data on existing risk prediction tools and risk factors provides a foundation for refining or automating current models, for instance via machine learning approaches that can iteratively incorporate risk factors to ease use and improve prediction of DRPs within specific clinical settings.<\/jats:p>","DOI":"10.1371\/journal.pdig.0001583","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:21:52Z","timestamp":1786036912000},"page":"e0001583","update-policy":"https:\/\/doi.org\/10.1371\/journal.pdig.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction tools to prioritise hospitalised adult patients at risk of drug related problems: An umbrella review"],"prefix":"10.1371","volume":"5","author":[{"given":"Daria S.","family":"Gutteridge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-9169","authenticated-orcid":true,"given":"Dona","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelina","family":"Stasinopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Calder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Marotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwin","family":"Patrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Macolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan","family":"Bidargaddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet K.","family":"Sluggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"1","key":"pdig.0001583.ref001","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12916-020-01774-9","article-title":"Preventable medication harm across health care settings: A systematic review and meta-analysis","volume":"18","author":"A Hodkinson","year":"2020","journal-title":"BMC Med"},{"issue":"3","key":"pdig.0001583.ref002","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40264-021-01144-1","article-title":"The extent of medication-related hospital admissions in Australia: A review from 1988 to 2021","volume":"45","author":"R Lim","year":"2022","journal-title":"Drug Saf"},{"issue":"1","key":"pdig.0001583.ref003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bcp.12944","article-title":"Adverse drug event reporting systems: A systematic review","volume":"82","author":"C Bailey","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"pdig.0001583.ref004","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199102073240605","article-title":"The nature of adverse events in hospitalized patients","volume":"324","author":"LL Leape","year":"1991","journal-title":"N Engl J Med"},{"key":"pdig.0001583.ref005","article-title":"Medical error-the third leading cause of death in the US","volume":"353","author":"MA Makary","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"pdig.0001583.ref006","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","article-title":"Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality","volume":"277","author":"DC Classen","year":"1997","journal-title":"JAMA"},{"issue":"15","key":"pdig.0001583.ref007","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies","volume":"279","author":"J Lazarou","year":"1998","journal-title":"JAMA"},{"issue":"2","key":"pdig.0001583.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes","volume":"4","author":"EC Davies","year":"2009","journal-title":"PLoS One"},{"key":"pdig.0001583.ref009","article-title":"Adverse drug events and medication errors in Australia","author":"WB Runciman","year":"2003","journal-title":"Int J Qual Health Care"},{"issue":"1","key":"pdig.0001583.ref010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jama.1995.03530010043033","article-title":"Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE prevention study Group","volume":"274","author":"DW Bates","year":"1995","journal-title":"JAMA"},{"issue":"1368","key":"pdig.0001583.ref011","first-page":"9","article-title":"The adverse drug event collaborative: A joint venture to measure medication-related patient harm","volume":"126","author":"ME Seddon","year":"2012","journal-title":"N Z Med J"},{"key":"pdig.0001583.ref012","year":"2001"},{"issue":"7","key":"pdig.0001583.ref013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055551","article-title":"Adverse drug reactions, multimorbidity and polypharmacy: A prospective analysis of 1 month of medical admissions","volume":"12","author":"R Osanlou","year":"2022","journal-title":"BMJ Open"},{"issue":"12","key":"pdig.0001583.ref014","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00228-017-2330-3","article-title":"The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis","volume":"73","author":"O Laatikainen","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"pdig.0001583.ref015","volume-title":"Preventing medication errors. IoM, editor","author":"P Aspden","year":"2006"},{"issue":"5","key":"pdig.0001583.ref016","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11096-015-0137-9","article-title":"Effectiveness of clinical pharmacy services: An overview of systematic reviews (2000-2010)","volume":"37","author":"I Rotta","year":"2015","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"pdig.0001583.ref017","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jppr.1959","article-title":"Advanced pharmacy australia clinical pharmacy standards","volume":"54","author":"M Dooley","year":"2024","journal-title":"Pharmacy Practice and Res"},{"issue":"2","key":"pdig.0001583.ref018","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/ijpp\/riaa022","article-title":"Analysis of the demographics and characteristics of the Australian pharmacist workforce 2013-2018: Decreasing supply points to the need for a workforce strategy","volume":"29","author":"JK Jackson","year":"2021","journal-title":"Int J Pharm Pract"},{"key":"pdig.0001583.ref019","doi-asserted-by":"crossref","DOI":"10.1136\/ejhpharm-2020-002365","article-title":"Patient prioritisation for hospital pharmacy services: Current approaches in the UK","volume":"28","author":"AS Abuzour","year":"2021","journal-title":"Eur J Hosp Pharm"},{"issue":"2","key":"pdig.0001583.ref020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jppr.1916","article-title":"Standard of practice in pharmacy informatics","volume":"54","author":"M Bakker","year":"2024","journal-title":"Pharmacy Practice and Res"},{"key":"pdig.0001583.ref021","year":"2016","journal-title":"Am J Health-Syst Pharm"},{"key":"pdig.0001583.ref022","unstructured":"Aggarwal A, Blochberger A, Cahill S, Maisuria R, Shaikh A, Wright P. Digital Capabilities for the Pharmacy Workforce. 2021."},{"issue":"4","key":"pdig.0001583.ref023","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11096-022-01424-5","article-title":"Consensus on the criteria for patient prioritization in hospital clinical pharmacy services: A Delphi study","volume":"44","author":"SF Botelho","year":"2022","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"pdig.0001583.ref024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjhci-2020-100253","article-title":"Adoption of clinical risk prediction tools is limited by a lack of integration with electronic health records","volume":"28","author":"V Sharma","year":"2021","journal-title":"BMJ Health Care Inform"},{"issue":"4","key":"pdig.0001583.ref025","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/bcp.15104","article-title":"Clinical usefulness of prediction tools to identify adult hospitalized patients at risk of drug-related problems: A systematic review of clinical prediction models and risk assessment tools","volume":"88","author":"K Deawjaroen","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"pdig.0001583.ref026","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/ejhpharm-2023-003857","article-title":"Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: A systematic review","volume":"31","author":"E Johns","year":"2024","journal-title":"Eur J Hosp Pharm"},{"issue":"5","key":"pdig.0001583.ref027","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/jamia\/ocad014","article-title":"Electronic health record-based prediction models for in-hospital adverse drug event diagnosis or prognosis: A systematic review","volume":"30","author":"IAR Yasrebi-de Kom","year":"2023","journal-title":"J Am Med Inform Assoc"},{"key":"pdig.0001583.ref028","first-page":"2079","article-title":"A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting","volume":"9","author":"TM Alhawassi","year":"2014","journal-title":"Clin Interv Aging"},{"issue":"10","key":"pdig.0001583.ref029","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s40264-021-01099-3","article-title":"Drug-related problems in hospitalised patients with chronic kidney disease: A systematic review","volume":"44","author":"WS Alruqayb","year":"2021","journal-title":"Drug Saf"},{"issue":"4","key":"pdig.0001583.ref030","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/bcp.12504","article-title":"An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients","volume":"79","author":"EB Boeker","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"pdig.0001583.ref031","doi-asserted-by":"crossref","DOI":"10.46658\/JBIMES-24-01","volume-title":"JBI Manual for Evidence Synthesis","author":"E Aromataris","year":"2024"},{"issue":"3","key":"pdig.0001583.ref032","article-title":"Checklist for systematic reviews and research syntheses","volume":"13","author":"E Aromataris","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"3","key":"pdig.0001583.ref033","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"E Aromataris","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"1","key":"pdig.0001583.ref034","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1186\/s12877-024-05288-4","article-title":"Factors associated with frailty in older people: An umbrella review","volume":"24","author":"M Boucham","year":"2024","journal-title":"BMC Geriatr"},{"key":"pdig.0001583.ref035","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"KGM Moons","year":"2025","journal-title":"BMJ"},{"key":"pdig.0001583.ref036","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Z J. JBI Data Extraction Form for Review for Systematic Reviews and Research Syntheses. 2024."},{"issue":"4","key":"pdig.0001583.ref037","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jamia\/ocz228","article-title":"A tutorial on calibration measurements and calibration models for clinical prediction models","volume":"27","author":"Y Huang","year":"2020","journal-title":"J Am Med Inform Assoc"},{"issue":"7","key":"pdig.0001583.ref038","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes","volume":"38","author":"RD Riley","year":"2019","journal-title":"Stat Med"},{"key":"pdig.0001583.ref039","volume-title":"Umbrella Reviews","author":"E Aromataris","year":"2020"},{"issue":"5","key":"pdig.0001583.ref040","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/jrsm.1658","article-title":"Estimating pairwise overlap in umbrella reviews: Considerations for using the corrected covered area (CCA) index methodology","volume":"14","author":"M Kirvalidze","year":"2023","journal-title":"Res Synth Methods"},{"issue":"6","key":"pdig.0001583.ref041","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/eurjcn\/zvaf012","article-title":"Umbrella reviews: A methodological guide","volume":"24","author":"RS Fernandez","year":"2025","journal-title":"Eur J Cardiovasc Nurs"},{"key":"pdig.0001583.ref042"},{"issue":"5","key":"pdig.0001583.ref043","first-page":"253","article-title":"A systematic review of the prospective studies on adverse drug reactions reported with anti-microbials among Indian patients","volume":"4","author":"P Kharb","year":"2022","journal-title":"Int J Acad Med Pharm"},{"issue":"10","key":"pdig.0001583.ref044","doi-asserted-by":"crossref","first-page":"25","DOI":"10.22159\/ajpcr.2018.v11i10.27759","article-title":"A systematic review of risk factors of adverse drug reactions in hospitalized patients","volume":"11","author":"MK Mudigubba","year":"2018","journal-title":"Asian J Pharm Clin Res"},{"issue":"2","key":"pdig.0001583.ref045","first-page":"64","article-title":"Screening tools used by clinical pharmacists to identify elderly patients at risk of drug-related problems on hospital admission: A systematic review","volume":"8","author":"A Brady","year":"2020","journal-title":"Pharmacy (Basel)"},{"issue":"17","key":"pdig.0001583.ref046","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.3390\/jcm11175185","article-title":"Systematic review of risk factors assessed in predictive scoring tools for drug-related problems in inpatients","volume":"11","author":"L Jung-Poppe","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"pdig.0001583.ref047","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/1574886312666170710192409","article-title":"Adverse drug reactions in critical care settings: A systematic review","volume":"12","author":"J Lisha","year":"2017","journal-title":"Curr Drug Saf"},{"issue":"2","key":"pdig.0001583.ref048","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bcp.14417","article-title":"Prevalence of adverse drug events and adverse drug reactions in hospital among older patients with dementia: A systematic review","volume":"87","author":"MA Sakiris","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"pdig.0001583.ref049","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40801-016-0083-4","article-title":"Risk factors associated with the requirement for pharmaceutical intervention in the hospital setting: A systematic review of the literature","volume":"3","author":"E Suggett","year":"2016","journal-title":"Drugs Real World Outcomes"},{"issue":"3","key":"pdig.0001583.ref050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/phar.2666","article-title":"Patient risk factors for opioid-related adverse drug events in hospitalized patients: A systematic review","volume":"42","author":"CH Yiu","year":"2022","journal-title":"Pharmacotherapy"},{"issue":"5","key":"pdig.0001583.ref051","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bcp.13514","article-title":"Systematic review of predictive risk models for adverse drug events in hospitalized patients","volume":"84","author":"N Falconer","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"pdig.0001583.ref052","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2147\/CIA.S65475","article-title":"Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models","volume":"9","author":"JM Stevenson","year":"2014","journal-title":"Clin Interv Aging"},{"key":"pdig.0001583.ref053","doi-asserted-by":"crossref","first-page":"20503121211039099","DOI":"10.1177\/20503121211039099","article-title":"Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: A systematic review and meta-analysis","volume":"9","author":"TM Yadesa","year":"2021","journal-title":"SAGE Open Med"},{"issue":"6","key":"pdig.0001583.ref054","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.sapharm.2018.09.009","article-title":"Patient prioritization for pharmaceutical care in hospital: A systematic review of assessment tools","volume":"15","author":"MA Alshakrah","year":"2019","journal-title":"Res Social Adm Pharm"},{"key":"pdig.0001583.ref055","first-page":"100348","article-title":"Drug-related problems in hospitalized patients with type 2 diabetes mellitus: A systematic review","volume":"12","author":"MH Awang Jihadi","year":"2023","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"pdig.0001583.ref056","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/ADM.0000000000000536","article-title":"Opioid Overdose in the hospital setting: A systematic review","volume":"14","author":"I Danovitch","year":"2020","journal-title":"J Addict Med"},{"issue":"6","key":"pdig.0001583.ref057","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ageing\/afaa188","article-title":"In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs-a systematic review and meta-analysis","volume":"49","author":"ELM Jennings","year":"2020","journal-title":"Age Ageing"},{"issue":"9","key":"pdig.0001583.ref058","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00228-019-02702-4","article-title":"Mortality among patients due to adverse drug reactions that occur following hospitalisation: A meta-analysis","volume":"75","author":"PB Patel","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"pdig.0001583.ref059","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007259","article-title":"A tool for prediction of risk of rehospitalisation and mortality in the hospitalised elderly: Secondary analysis of clinical trial data","volume":"5","author":"A Alassaad","year":"2015","journal-title":"BMJ Open"},{"issue":"13","key":"pdig.0001583.ref060","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archinternmed.2010.153","article-title":"Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: The GerontoNet ADR risk score","volume":"170","author":"G Onder","year":"2010","journal-title":"Arch Intern Med"},{"issue":"1","key":"pdig.0001583.ref061","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11096-009-9352-6","article-title":"Electronic screening of medical records to detect inpatients at risk of drug-related problems","volume":"32","author":"I Roten","year":"2010","journal-title":"Pharm World Sci"},{"issue":"10","key":"pdig.0001583.ref062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111254","article-title":"Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay: Brighton Adverse Drug Reactions Risk (BADRI) model","volume":"9","author":"B Tangiisuran","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"pdig.0001583.ref063","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00044011-199713010-00006","article-title":"Development of a risk model for adverse drug events in the elderly","volume":"13","author":"JC McElnay","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"2","key":"pdig.0001583.ref064","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s41999-018-0030-x","article-title":"The adverse drug reaction risk in older persons (ADRROP) prediction scale: Derivation and prospective validation of an ADR risk assessment tool in older multi-morbid patients","volume":"9","author":"D O\u2019Mahony","year":"2018","journal-title":"Eur Geriatr Med"},{"key":"pdig.0001583.ref065","article-title":"Adverse drug reactions in elderly patients: How to predict them?","volume":"5","author":"C Passarelli","year":"2007","journal-title":"Einstein"},{"issue":"5","key":"pdig.0001583.ref066","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.eurger.2011.07.002","article-title":"Risk factors for adverse drug events in hospitalized elderly patients: A geriatric score","volume":"2","author":"C Trivalle","year":"2011","journal-title":"European Geriatric Medicine"},{"issue":"2","key":"pdig.0001583.ref067","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13663","article-title":"Development and validation of a score to assess risk of medication errors detected during medication reconciliation process at admission in internal medicine unit: SCOREM study","volume":"75","author":"Y Audurier","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"8","key":"pdig.0001583.ref068","article-title":"Prediction of clinically relevant adverse drug events in surgical patients","volume":"13","author":"JM Bos","year":"2018","journal-title":"PLoS One"},{"issue":"23","key":"pdig.0001583.ref069","doi-asserted-by":"crossref","DOI":"10.2146\/ajhp140827","article-title":"Use of an electronic clinical scoring system to prioritize patients\u2019 medication-monitoring needs","volume":"72","author":"MK Carlson","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"pdig.0001583.ref070","article-title":"Developing and implementing a pharmacy risk screening tool","author":"R Cottrell","year":"2013","journal-title":"Hospital Pharmacy Europe"},{"issue":"5","key":"pdig.0001583.ref071","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/jcpt.12301","article-title":"Development of an obstetrics triage tool for clinical pharmacists","volume":"40","author":"JR Covvey","year":"2015","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"pdig.0001583.ref072","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jep.12276","article-title":"Enhanced clinical pharmacy service targeting tools: risk-predictive algorithms","volume":"21","author":"FWD El Hajji","year":"2015","journal-title":"J Eval Clin Pract"},{"issue":"6","key":"pdig.0001583.ref073","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/ejhpharm-2016-001165","article-title":"Validation of the assessment of risk tool: patient prioritisation technology for clinical pharmacist interventions","volume":"24","author":"N Falconer","year":"2017","journal-title":"Eur J Hosp Pharm"},{"issue":"4","key":"pdig.0001583.ref074","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2146\/ajhp130247","article-title":"Development of an electronic patient prioritization tool for clinical pharmacist interventions","volume":"71","author":"N Falconer","year":"2014","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"pdig.0001583.ref075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmjqs-2018-008335","article-title":"Development and performance evaluation of the Medicines Optimisation Assessment Tool (MOAT): A prognostic model to target hospital pharmacists\u2019 input to prevent medication-related problems","volume":"28","author":"C Geeson","year":"2019","journal-title":"BMJ Qual Saf"},{"issue":"2","key":"pdig.0001583.ref076","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ejhpharm-2015-000829","article-title":"Evaluation of a pharmaceutical assessment screening tool to measure patient acuity and prioritise pharmaceutical care in a UK hospital","volume":"24","author":"RP Hickson","year":"2017","journal-title":"Eur J Hosp Pharm"},{"issue":"6","key":"pdig.0001583.ref077","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1553-2712.2012.01379.x","article-title":"Clinical decision rules to improve the detection of adverse drug events in emergency department patients","volume":"19","author":"CM Hohl","year":"2012","journal-title":"Acad Emerg Med"},{"issue":"21","key":"pdig.0001583.ref078","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.2146\/ajhp160387","article-title":"Identifying and characterizing preventable adverse drug events for prioritizing pharmacist intervention in hospitals","volume":"74","author":"N Jeon","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"pdig.0001583.ref079","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016610","article-title":"Drug-associated risk tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems","volume":"8","author":"CP Kaufmann","year":"2018","journal-title":"BMJ Open"},{"issue":"12","key":"pdig.0001583.ref080","article-title":"Development and validation of a clinical instrument to predict risk of an adverse drug reactions in hospitalized patients","volume":"15","author":"SIVC Lima","year":"2020","journal-title":"PLoS One"},{"key":"pdig.0001583.ref081","first-page":"1342","article-title":"Development of risk score to hospitalized patients for clinical pharmacy rationalization in a high complexity hospital","volume":"30","author":"J Martinbiancho","year":"2011","journal-title":"Latin American Journal of PhARMACY"},{"issue":"3","key":"pdig.0001583.ref082","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2146\/ajhp170184","article-title":"Development and validation of a transitions-of-care pharmacist tool to predict potentially avoidable 30-day readmissions","volume":"75","author":"LH McAuliffe","year":"2018","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"pdig.0001583.ref083","article-title":"Improving medication safety: Development and impact of a multivariate model-based strategy to target high-risk patients","volume":"12","author":"T-L Nguyen","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"pdig.0001583.ref084","article-title":"Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease","volume":"9","author":"FS Sharif-Askari","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"pdig.0001583.ref085","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/pds.3331","article-title":"Clinical prediction rule to identify high-risk inpatients for adverse drug events: The JADE Study","volume":"21","author":"M Sakuma","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"pdig.0001583.ref086","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/bcpt.12473","article-title":"Detection of patients at high risk of medication errors: Development and validation of an algorithm","volume":"118","author":"EA Saedder","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"pdig.0001583.ref087","author":"E Suggett","year":"2017"},{"issue":"9","key":"pdig.0001583.ref088","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/pds.3634","article-title":"Design of a score to identify hospitalized patients at risk of drug-related problems","volume":"23","author":"O Urbina","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"23","key":"pdig.0001583.ref089","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2146\/ajhp160995","article-title":"Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events","volume":"74","author":"AG Winterstein","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"pdig.0001583.ref090","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2165\/00002018-200831090-00007","article-title":"Risk factors associated with adverse drug reactions following hospital admission: A prospective analysis of 907 patients in two German university hospitals","volume":"31","author":"Y Zopf","year":"2008","journal-title":"Drug Saf"},{"issue":"3","key":"pdig.0001583.ref091","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/bcp.14560","article-title":"Development and validation of the Adverse Inpatient Medication Event model (AIME)","volume":"87","author":"N Falconer","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"pdig.0001583.ref092","article-title":"Impact of early in-hospital medication review by clinical pharmacists on health services utilization","volume":"12","author":"CM Hohl","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"pdig.0001583.ref093","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/acem.13407","article-title":"Prospective validation of clinical criteria to identify emergency department patients at high risk for adverse drug events","volume":"25","author":"CM Hohl","year":"2018","journal-title":"Acad Emerg Med"},{"issue":"6","key":"pdig.0001583.ref094","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-021284","article-title":"Assessing the ability of the Drug-Associated Risk Tool (DART) questionnaire to stratify hospitalised older patients according to their risk of drug-related problems: A cross-sectional validation study","volume":"8","author":"D St\u00e4mpfli","year":"2018","journal-title":"BMJ Open"},{"issue":"6","key":"pdig.0001583.ref095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ageing\/afs046","article-title":"Adverse drug reactions in older patients during hospitalisation: Are they predictable?","volume":"41","author":"MN O\u2019Connor","year":"2012","journal-title":"Age Ageing"},{"issue":"2","key":"pdig.0001583.ref096","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40266-016-0428-4","article-title":"Predicting the risk of adverse drug reactions in older inpatients: External validation of the GerontoNet ADR risk score using the CRIME cohort","volume":"34","author":"M Petrovic","year":"2017","journal-title":"Drugs Aging"},{"issue":"5","key":"pdig.0001583.ref097","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11096-016-0345-y","article-title":"Risk of prescribing errors in acutely admitted patients: A pilot study","volume":"38","author":"DK Bonnerup","year":"2016","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"pdig.0001583.ref098","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bcpt.13636","article-title":"External validation of the Medication Risk Score in polypharmacy patients in general practice: A tool for prioritizing patients at greatest risk of potential drug-related problems","volume":"129","author":"K H\u00f8j","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"pdig.0001583.ref099","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jsps.2018.02.020","article-title":"Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period","volume":"26","author":"O Ferr\u00e1ndez","year":"2018","journal-title":"Saudi Pharm J"},{"key":"pdig.0001583.ref100","doi-asserted-by":"crossref","first-page":"20552076251388145","DOI":"10.1177\/20552076251388145","article-title":"Artificial intelligence in clinical pharmacy-A systematic review of current scenario and future perspectives","volume":"11","author":"SS Alqahtani","year":"2025","journal-title":"Digit Health"},{"issue":"8","key":"pdig.0001583.ref101","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.sapharm.2024.05.003","article-title":"The adverse inpatient medication event and frailty (AIME-frail) risk prediction model","volume":"20","author":"N Falconer","year":"2024","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"pdig.0001583.ref102","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4212\/cjhp.v69i4.1583","article-title":"Patient characteristics associated with adverse drug events in hospital: An overview of reviews","volume":"69","author":"S Mihajlovic","year":"2016","journal-title":"Can J Hosp Pharm"},{"issue":"10","key":"pdig.0001583.ref103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205426","article-title":"Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: A systematic review of systematic reviews","volume":"13","author":"D Wolfe","year":"2018","journal-title":"PLoS One"},{"key":"pdig.0001583.ref104","unstructured":"SA Health. High risk medicines. In: Government of South Australia, editor. Clinical Programs and Practice Guidelines."},{"key":"pdig.0001583.ref105"},{"key":"pdig.0001583.ref106","year":"2020"},{"key":"pdig.0001583.ref107"},{"key":"pdig.0001583.ref108","author":"Royal College of Psychiatrists","year":"2014"},{"key":"pdig.0001583.ref109","article-title":"ASHP therapeutic position statement on the use of antipsychotic medications in the treatment of adults with schizophrenia and schizoaffective disorder","author":"J Noel","year":"2018","journal-title":"American Journal of Health-System Pharmacy"},{"key":"pdig.0001583.ref110","unstructured":"Australian Medicines Handbook. Antipsychotics. Australian Medicines Handbook. 2025."},{"issue":"10","key":"pdig.0001583.ref111","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4140\/TCP.n.2020.419","article-title":"High-risk medication use in older residents of long-term care facilities: Prevalence, harms, and strategies to mitigate risks and enhance use","volume":"35","author":"JK Sluggett","year":"2020","journal-title":"Sr Care Pharm"},{"key":"pdig.0001583.ref112","unstructured":"Institute for Safe Medication Practices. ISMP List of High-Alert Medications in Acute Care Settings. 2018."},{"key":"pdig.0001583.ref113","year":"2017"},{"key":"pdig.0001583.ref114","year":"2019"},{"issue":"3","key":"pdig.0001583.ref115","first-page":"103","article-title":"The effects of pharmacist interventions on patients with polypharmacy","volume":"4","author":"EC Chumney","year":"2006","journal-title":"Pharm Pract (Granada)"},{"key":"pdig.0001583.ref116","year":"2020"}],"container-title":["PLOS Digital Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pdig.0001583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:22:15Z","timestamp":1786036935000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pdig.0001583"}},"subtitle":[],"editor":[{"given":"Bushra Ali","family":"Sherazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":116,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pdig.0001583","relation":{},"ISSN":["2767-3170"],"issn-type":[{"value":"2767-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}